Home
Conditions
Communicable Diseases

Clinical trial condition

Communicable Diseases

Explore clinical trials studying Communicable Diseases. Study availability and eligibility vary by location and protocol.

9,172 public trials 550 recruiting studies

Refine in advanced search Browse all conditions

Communicable Diseases trial results

Completed

Current Treatment of HCV Infection After HSCT

NCT03014986

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations: Centre Hospitalier de Meaux Meaux, France

Ospedale San Raffaele s.r.l. Milan, Italy

Ospedale Santa Maria della Misericordia Perugia, Italy

Ospedale Civile Pescara, Italy

View Trial Details

Completed

New Methods to Measure the Immune Response to Hepatitis B Vaccine

NCT01821547

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
Locations: Centre for Clinical Vaccinology & Tropical Medicine (CCVTM) Oxford, Oxfordshire, United Kingdom

View Trial Details

Completed

TD-6450 SAD and MAD in Healthy Subjects

NCT02022306

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations: ICON Development Solutions San Antonio, Texas, United States

View Trial Details

Completed

A Controlled Trial to Evaluate the Effects of GanedenBC30 on the Immune System

NCT01184456

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +15 more
Locations: AHF Research Center Beverly Hills, California, United States

View Trial Details

Completed

A Study to Evaluate the Mass Balance Absorption and AME of VBR

NCT04637139

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
Locations: Pharmaron CPC Baltimore, Maryland, United States

View Trial Details

Completed

Open-label Study of Dolutegravir (DTG) or Efavirenz (EFV) for Human Immunodeficiency Virus (HIV) - Tuberculosis (TB) Co-infection

NCT02178592

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Coinfection, +15 more
Locations: GSK Investigational Site Ciudad de Buenos Aires, Buenos Aires, Argentina

GSK Investigational Site Rosario, Santa Fe Province, Argentina

GSK Investigational Site Manaus, Amazonas, Brazil

GSK Investigational Site Salvador, Estado de Bahia, Brazil

View all 28 locations

View Trial Details

Completed

Non-Communicable Diseases and Antiretroviral Therapy Outcomes in the RapIT Study Population

NCT02012972

Conditions: Acquired Immunodeficiency Syndrome, Antiretroviral Therapy, Highly Active, Blood-Borne Infections, +25 more
Locations: Thuthukani Health Centre Johannesburg, Gauteng, South Africa

View Trial Details

Completed

Psilocybin-assisted Group Therapy for Demoralization in Long-term AIDS Survivors

NCT02950467

Conditions: Acquired Immunodeficiency Syndrome, Behavior, Behavioral Symptoms, +18 more
Locations: University of California, San Francisco San Francisco, California, United States

View Trial Details

Completed

Does the HPV Vaccine Cause the Same Response in Adolescent Kidney and Liver Transplant Patients as in Healthy Controls?

NCT01101750

Conditions: Cervical Cancer, Communicable Diseases, DNA Virus Infections, +28 more
Locations: Georgetown University Hospital Washington D.C., District of Columbia, United States

Childrens National Medical Center Washington D.C., District of Columbia, United States

View Trial Details

Completed

Efficacy and Tolerability of Topical LFX453 for External Genital Warts

NCT02482428

Conditions: Communicable Diseases, Condylomata Acuminata, DNA Virus Infections, +17 more
Locations: Novartis Investigative Site Arlington Heights, Illinois, United States

View Trial Details

Communicable Diseases

Communicable Diseases trial results

Related conditions